Appeals Court Reinstates Risperdal Gynecomastia Claims Against Johnson & Johnson
A California appeals court has reinstated the eligibility of thousands of cases against Johnson & Johnson and its Janssen Pharmaceuticals subsidiary, alleging that the company’s antipsychotic drug Risperdal causes abnormal […]
Appeals Court Reinstates Risperdal Gynecomastia Claims Against Johnson & Johnson Read More »